(“Robex” or the “Company”) (TSX-V: RBX | ASX: RXR | OTC: RSRBF | Börse Frankfurt: RB4) is pleased to report on its activities ...
Six pharmaceutical companies have applied to make a generic version of semaglutide, and competition will continue to heat up in the rapidly growing weight-loss market ...
Senate Democratic leader Chuck Schumer said Democrats won't provide needed votes until U.S. Immigration and Customs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results